Minerva Neurosciences Inc (NERV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Minerva Neurosciences Inc, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.21
−0.90% today
Market cap
$106M
Overall quality
—
Kronos AI 30-day
+89.1%
8 of 8 simulated paths end higher
Minerva Neurosciences Inc (NERV) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $106M. It trades at $2.21, down 0.90% today. 2 analysts' average target of $8.50 implies +284.6% from today's price. Kronos AI's 30-day forecast is +89.1% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $8.50 |
| Low – high | $7.00 – $10.00 |
| Analysts | 2 |
| Upside to average | +284.6% |
Kronos AI 30-day forecast
| Expected close | $4.22 (+89.1%) |
| Likely range | +81.4% … +111.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.